Skip to main content
. Author manuscript; available in PMC: 2021 May 19.
Published in final edited form as: Cancer Lett. 2018 Oct 10;440-441:82–93. doi: 10.1016/j.canlet.2018.10.007

Fig. 2. Effect of selonsertib on the viability of parental and ABCG2-, ABCC1-, ABCC10-overexpressing cell lines.

Fig. 2.

(A) Concentration-dependent viability curves for NCI-H460 and NCI-H460/MX20, (B) S1 and S1-M1–80, (C) HEK293/pcDNA3.1, HEK293/ABCG2–482-R2, HEK293/ABCG2–482-G2 and HEK293/ABCG2–482-T7, (D) KB-3–1 and KB-CV60, (E) HEK293/pcDNA3.1 and HEK293/ABCC1 and (F) HEK293/pcDNA3.1 and HEK293/ABCC10 cell lines incubated with selonsertib for 72 h. Other details same as given in the legend to Fig. 1.